(b)(4).Investigation summary: a device history record review was completed by our quality engineer team for provided lot number 58623.The review did not reveal any detected abnormalities during the production process that could have contributed to this defect and all quality tests were found to be within specification.As a sample was unavailable for return, a thorough sample investigation could not be completed.Based on the investigation results, an exact cause for this incident could not be identified.Further action has not been determined necessary at this time.Our quality team will continue to monitor the manufacturing process for this defect and other emerging trends.Investigation conclusion: based on the investigation and with no sample analysis the symptom reported by the customer could not be confirmed.We will continue monitoring the complaint trend for the product and symptom.With no sample analysis a probable root cause could not be offered.
|
It was reported that the syringe 5ml saline fill (b)(4) sp experienced syringe barrel damage/deformation and leakage.The following information was provided by the initial reporter: on (b)(6) 2020, the patient was admitted to their hospital for diabetes treatment.After the infusion, the flush sealed the indwelling needle was needed.After taking out the flush, it was found that the package was squeezed and deformed to leak.Replaced with a new precharge.
|